Current Funding Opportunities

To visit the NCI grant site, click here


Use your device's search function to find a specific disease or funding source. 


Breast 

Avon Breast Cancer Crusade 2017 Funding 

These research initiative funds translational research using clinical studies, human cell culture, epidemiologic, and other progressive approaches to understand the causes of breast cancer and develop new treatments.


Access to Care - Breast Health Outreach Program

Supports community-based organizations to educate the public on the importance of good breast health and link underserved women to appropriate breast health services. Range from $25,000-$80,000 per year. 

Application Deadline: August 17, 2017



Access to Care - Support Services Program

Supports programs providing services and education to women and men diagnosed with breast cancer, including nutrition support, counseling and referral programs, financial assistance programs, and information services. Application is by invitation only. To seek an invitation, please send a description of the proposed program to grants@avonbcc.org.


Department of Defense Breast Cancer Research Program Anticipated Funding Opportunities for Fiscal Year 2017

FY17 BCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on Grants.gov in March 2017.  Pre-application and application deadlines will be available when the Program Announcements are released. Applications must be submitted through the federal government’s single-entry portal, Grants.gov.  Submission deadlines are not available until the Program Announcements are released.  

Breakthrough Award
• Investigators at all academic levels (or equivalent)
Senior postdoctoral fellows who do not meet the eligibility requirements of the Breakthrough Fellowship Award are encouraged to apply under Funding Levels 1 and 2

Funding Level 1:  Innovative, high-risk/high-reward research that is in the earliest stages of idea development.  Research with potential to yield new avenues of investigation.  Proof of concept.  No preliminary data required.
Funding Level 2:  Research that is already supported by preliminary data and has potential to make significant advancements toward clinical translation.
Funding Level 3:  Advanced translational studies that have potential for near-term clinical investigation.  Small-scale clinical trials may apply.
Funding Level 4:  Large-scale projects that will transform and revolutionize the clinical management and/or prevention of breast cancer.  Near-term clinical impact is expected. Human clinical testing is required. PIs are expected to have experience in successfully leading large-scale projects

Deadlines for Full Applications: Level 1 & 2 due June 15, Level 3 & 4 due August 31

Innovator Award
Associate Professor or above (or equivalent).

Deadline for Application: August 31, 2017

Distinguished Investigator Awar d
Assistant Professor or above (or equivalent) and more than 6 years beyond the PI’s last training position as of the application submission deadline

Deadline for Application: August 31, 2017

Colorectal


Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) 


This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.  
 

Application Due Date: Application Receipt/Submission Date(s): August 15, 2017; February 15, 2018; August 15, 2018, by 5:00 PM local time of applicant organization.

 

Heme/Onc


Leukemia & Lymphoma Society's (LLS) Career Development Program (CDP)

The Leukemia & Lymphoma Society's (LLS) Career Development Program (CDP) provides stipends so that you can devote yourself to researching questions of direct relevance to hematological malignancies and/or relevant pre-malignant conditions. LLS offers career development awards to postdoctoral fellows as well as early career, independent investigators. 

This year the Career Development application will be completed in 3 phases. See guidelines and instructions for full details. 

DeadlinesEligibility Phase: September 1, 2017 Abstract Phase: September 15, 2017 Full Application Phase: October 3, 2017 

Learn More>>


Gilead Sciences Research Scholars Program in Hematology/Oncology

The Gilead Sciences Research Scholars Programs provide financial support to junior faculty researchers for a 2-year period. Each award is funded up to $130,000, to be paid in annual installments of up to $65,000 per year for 2 years. Any questions, please email HemOncResearchScholars1@contacthmc.com

Application Deadline: September 8, 2017

Lung 

Department of Defense Lung Cancer Research Program Funding Opportunities 

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that are available for electronic downloading from the Grants.gov website. 

Concept Award – Letter of Intent due July 27

Career Development Award – Letter of Intent due September 13


Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) 

 
This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.  
 

Application Due Date: Application Receipt/Submission Date(s): August 15, 2017; February 15, 2018; August 15, 2018, by 5:00 PM local time of applicant organization.


Ovarian

Department of Defense Ovarian Cancer Research Program Funding Opportunities

FY17 OCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on Grants.gov in February 2017.  Pre-application and application deadlines will be available when the Program Announcements are released. 

Clinical Development Award
Must be an independent investigator at or above the level of Assistant Professor (or equivalent)

Investigator-Initiated Research Award
Must be an independent investigator at or above the level of Assistant Professor (or equivalent)

Ovarian Cancer Academy Award – Early-Career Investigator
Must be within 3 years of his/her last postdoctoral research position (Ph.D) or clinical fellowship (M.D.), or equivalent as of the full application submission deadline.  A letter attesting to eligibility is required.

Pilot Award
Established Investigator:  Independent investigator for whom it has been more than 3 years since his/her last postdoctoral research position (Ph.D) or clinical fellowship (M.D.), or equivalent; or
Early-Career Investigator:  Investigators must meet one of the following criteria by the application submission date: Must be within 3 years of his/her last postdoctoral research position (Ph.D) or clinical fellowship (M.D.) OR In a postdoctoral research position (Ph.D), or clinical fellowship (M.D.), or equivalent.  

Applications must be submitted through the federal government’s single-entry portal, Grants.gov.  Submission deadlines are not available until the Program Announcements are released.  


Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01) 


This Funding Opportunity Announcement (FOA) encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. Available data associated with the biospecimens includes demographic, diet, lifestyle, smoking, screening results, and clinical data. This FOA supports a wide range of cancer research including, but not limited to, biochemical and genetic analyses of cancer risk, as well as discovery and validation of early detection biomarkers. The proposed research project must involve use of PLCO biospecimens; additionally, it should also take advantage of the unique characteristics of the PLCO biospecimens. Research projects that do not involve the use of PLCO biospecimens will not be supported under this FOA.  
 

Application Due Date: Application Receipt/Submission Date(s): August 15, 2017; February 15, 2018; August 15, 2018, by 5:00 PM local time of applicant organization.

 

Pancreatic


The Pancreatic Cancer Detection Consortium (U01)

This Funding Opportunity Announcement (FOA) invites applications from multi-disciplinary teams of researchers and clinicians to establish the Pancreatic Cancer Detection Consortium (PCDC) to conduct research to improve the detection of early stage pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions.

Application Due Dates: September 21, 2017, April 6, 2018

Learn More>>

Pediatric

Alex's Lemonade Stand Foundation (ALSF) Nurse Researcher Grants  

ALSF's Nurse Researcher Grants program is dedicated to improving the quality of life for young cancer patients and their families by supporting studies to discover better ways to care for children undergoing treatment. 

This year, ALSF is offering two Nurse Researcher grants:

Discovery Grant totaling $100,000 over two years: The Discovery Grant supports independent and experienced nurse researchers for projects focusing on topics and issues related to the quality of nursing care and quality of life for children with cancer. 

Application deadline: August 21, 2017


Nurse Researcher Fellowship totaling $100,000 over two years: The Fellowship Grant supports early career nurse researchers who will be guided in their projects by a mentor and their institution. 

Application deadline: September 25, 2017

Prostate

Department of Defense Prostate Cancer Research Program Funding Opportunities for Fiscal Year 2017 (FY17)

The PCRP’s FY17 mission is to find and fund research that will lead to the elimination of death from prostate cancer and enhance the well-being of men experiencing the impact of the disease. FY17 PCRP Program Announcements and General Application Instructions for the following award mechanisms are posted on Grants.gov

Clinical Consortium Award – Letter of Intent due August 24, 2017 

Prostate Cancer Pathology Resource Network Award - Preapplication due August 24, 2017

Learn More>>

Alex's Lemonade Stand Foundation (ALSF)

Nurse Researcher Grants

ALSF's Nurse Researcher Grants program is dedicated to improving the quality of life for young cancer patients and their families by supporting studies to discover better ways to care for children undergoing treatment. 

This year, ALSF is offering two Nurse Researcher grants:

Discovery Grant totaling $100,000 over two years: The Discovery Grant supports independent and experienced nurse researchers for projects focusing on topics and issues related to the quality of nursing care and quality of life for children with cancer. 

Application deadline: August 21, 2017

Nurse Researcher Fellowship totaling $100,000 over two years: The Fellowship Grant supports early career nurse researchers who will be guided in their projects by a mentor and their institution. 

Application deadline: September 25, 2017

American Cancer Society

AMERICAN CANCER SOCIETY-MELANOMA RESEARCH ALLIANCE RESEARCH FOR PROPOSALS/MULTIDISCIPLINARY TEAM AWARD: Understanding, Preventing, and Managing Immunotherapy-related Adverse Events (irAEs) Associated with Checkpoint Inhibition for Melanoma and Other Cancers

To facilitate research focused on prevention, risk, early detection, and management of short- and long-term immune-related adverse events (irAEs) associated with FDA-approved or late-stage development checkpoint cancer immunotherapies for melanoma and other cancers.

Deadline for LOI's: August 1, 2017 (If invited to app,y, full applications are due October 31, 2017) 

Learn More>>


AMERICAN CANCER SOCIETY-MELANOMA RESEARCH ALLIANCE RESEARCH FOR PROPOSALS/Pilot Funding Awards

This Request for Applications (RFA) is intended to provide support for pilot or exploratory projects whose purpose is to test interventions, develop research methodologies and explore novel areas as defined in the RFA.

Application Deadline: October 16, 2017 

Learn More>>

AVON 

Avon Breast Cancer Crusade 2017 Funding 

These research initiative funds translational research using clinical studies, human cell culture, epidemiologic, and other progressive approaches to understand the causes of breast cancer and develop new treatments.


Access to Care - Breast Health Outreach Program

Supports community-based organizations to educate the public on the importance of good breast health and link underserved women to appropriate breast health services. Range from $25,000-$80,000 per year. 

Application Deadline: August 17, 2017



Access to Care - Support Services Program

Supports programs providing services and education to women and men diagnosed with breast cancer, including nutrition support, counseling and referral programs, financial assistance programs, and information services. Application is by invitation only. To seek an invitation, please send a description of the proposed program to grants@avonbcc.org.


Elsa U. Pardee Foundation 


The Pardee Foundation provides support to investigators in U.S. nonprofit institutions proposing research aimed at identifying new treatments or cures for cancer. The foundation particularly encourages grant applications for a one-year period that will demonstrate the capabilities of new cancer researchers, or new cancer approaches by established cancer researchers. It is anticipated that this early-stage funding may lead to subsequent and expanded support from a government agency. 

Deadline for Applications: August 31, 2017

Gilead

Gilead Sciences Research Scholars Program in Hematology/Oncology

The Gilead Sciences Research Scholars Programs provide financial support to junior faculty researchers for a 2-year period. Each award is funded up to $130,000, to be paid in annual installments of up to $65,000 per year for 2 years. Any questions, please email HemOncResearchScholars1@contacthmc.com

Application Deadline: September 8, 2017

Leukemia & Lymphoma Society 


Career Development Program (CDP)

The Leukemia & Lymphoma Society's (LLS) Career Development Program (CDP) provides stipends so that you can devote yourself to researching questions of direct relevance to hematological malignancies and/or relevant pre-malignant conditions. LLS offers career development awards to postdoctoral fellows as well as early career, independent investigators. 

This year the Career Development application will be completed in 3 phases. See guidelines and instructions for full details. 

Deadlines: Eligibility Phase: September 1, 2017 Abstract Phase: September 15, 2017 Full Application Phase: October 3, 2017 

Learn More>>

Melanoma Research Alliance


AMERICAN CANCER SOCIETY-MELANOMA RESEARCH ALLIANCE RESEARCH FOR PROPOSALS/MULTIDISCIPLINARY TEAM AWARD: Understanding, Preventing, and Managing Immunotherapy-related Adverse Events (irAEs) Associated with Checkpoint Inhibition for Melanoma and Other Cancers

To facilitate research focused on prevention, risk, early detection, and management of short- and long-term immune-related adverse events (irAEs) associated with FDA-approved or late-stage development checkpoint cancer immunotherapies for melanoma and other cancers.

Deadline for LOI's: August 1, 2017 (If invited to app,y, full applications are due October 31, 2017) 

Learn More>>


AMERICAN CANCER SOCIETY-MELANOMA RESEARCH ALLIANCE RESEARCH FOR PROPOSALS/Pilot Funding Awards

This Request for Applications (RFA) is intended to provide support for pilot or exploratory projects whose purpose is to test interventions, develop research methodologies and explore novel areas as defined in the RFA.

Application Deadline: October 16, 2017 

Learn More>>

NIH/NCI


Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01) and (R21)

This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival.


Examination of Survivorship Care Planning Efficacy and Impact (R21) and (R01)


The purpose of these Funding Opportunity Announcements (FOAs) is to stimulate developmental research evaluating the effect of care planning on self-management of late effects of cancer therapy; adherence to medications, cancer screening, and health behavior guidelines; utilization of follow-up care; survivors' health and psychosocial outcomes. How organizational-level factors influence the implementation of care planning and its associated costs is also of interest.

Application Receipt/Submission Date(s): Multiple dates, see here




Emerging Questions in Cancer Systems Biology (U01)

This Funding Opportunity Announcement (FOA) invites cooperative agreement applications for Research Projects that utilize systems biology approaches to address emerging questions in cancer initiation, progression, and treatment.

Application Receipt/Submission Date(s): November 24, 2017; June 22, 2018; November 23, 2018, by 5:00 PM local time of applicant organization.

Learn More>>


Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01)

This Funding Opportunity Announcement (FOA) encourages applications from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for preclinical or clinical molecular diagnosis or in vitro imaging that are designed to solve a targeted cancer problem.

Expiration date: January 8, 2018

Learn More>>


Cooperative Agreement to Develop Targeted Agents for Use with Systemic Agents Plus Radiotherapy (U01) 

The purpose of this Funding Opportunity Announcement (FOA) is to invite cooperative agreement (U01) applications that propose studies to enhance pre-clinical in vitro and in vivo testing of NCI-prioritized molecularly targeted anti-cancer agents for use with radiation therapy combined with systemic chemotherapy.

Application Due Dates: July 14, 2017; December 14, 2017 

Learn More>> 



Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests (U01)

This Funding Opportunity Announcement (FOA) encourages applications that strengthen the science of multilevel effects of cancer care interventions by addressing the problem of incomplete follow-up to abnormal screening tests for breast, colorectal, cervical and lung cancers.

Application Due Dates: September 21, 2017

Learn More>> 


The Pancreatic Cancer Detection Consortium (U01)

This Funding Opportunity Announcement (FOA) invites applications from multi-disciplinary teams of researchers and clinicians to establish the Pancreatic Cancer Detection Consortium (PCDC) to conduct research to improve the detection of early stage pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions.

Application Due Dates:September 21, 2017, April 6, 2018

Learn More>>


Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (U01)

This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research.

Application Receipt/Submission Date(s): November 30, 2017; May 30, 2018; November 30, 2018, by 5:00 PM local time of applicant organization.

Learn More>>


Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20)

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites P20 planning grant applications for  developing collaborative partnership between institutions serving underserved health disparity populations and underrepresented students (ISUPS) and NCI- designated Cancer Centers.

Application Due Dates: January 29, 2018

Learn More>> 


Cancer Research Education Grants Program to Promote Diversity - Research Experiences (R25)

To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Research Experiences.

Application Receipt/Submission Date(s): Multiple dates, see announcement.

Learn More>>


Cancer Research Education Grants Program to Promote Diversity - Courses for Skills Development (R25)

Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients, as well as the cause and reduction of cancer health disparities in accordance with the overall mission of the NCI.  

Application Receipt/Submission Date(s): Standard Dates apply.  

Learn More>> 


Exploratory Grants in Cancer Epidemiology and Genomics Research (R21)
This funding opportunity announcement (FOA) invites applications for research on cancer epidemiology, genomics, and risk assessment. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance cancer research.

Application Receipt/Submission Date(s): July 19, 2017; November 22, 2017; March 22, 2018; July 19, 2018; November 22, 2018; March 22, 2018, by 5:00 PM local time of applicant organization.

Learn More>>

Pilot and Feasibility Studies Evaluating the Role of RNA Modifications (the 'epitranscriptome') in Cancer Biology (R21)
This Funding Opportunity Announcement (FOA) encourages basic research into the role of RNA chemical modifications and their corresponding writers, readers and erasers in the initiation and progression of cancer.

Application Receipt/Submission Date(s): July 19, 2017; November 22, 2017; March 22, 2018; July 19, 2018; November 22, 2018; March 22, 2018, by 5:00 PM local time of applicant organization.

Learn More>>

Clinical and Translational Exploratory/Developmental Studies (R21)
This Funding Opportunity Announcement (FOA) supports the development of new exploratory research in cancer diagnosis, treatment, imaging, symptom/toxicity, and prevention clinical trials; correlative studies associated with clinical trials; novel cancer therapeutic, symptom/toxicity, and preventive agent development, radiotherapy development activities, and mechanism-driven combinations; and innovative preclinical studies--including the use of new clinically-relevant models and imaging technologies--which could lead to first-in-human clinical trials.

Application Receipt/Submission Date(s): July 19, 2017; November 22, 2017; March 22, 2018; July 19, 2018; November 22, 2018; March 22, 2018, by 5:00 PM local time of applicant organization.

Learn More>> 




Pancreatic Cancer Action Network


The Pancreatic Cancer Detection Consortium (U01) 

This Funding Opportunity Announcement (FOA) invites applications from multi-disciplinary teams of researchers and clinicians to establish the Pancreatic Cancer Detection Consortium (PCDC) to conduct research to improve the detection of early stage pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions. 

Application Due Dates: September 21, 2017, April 6, 2018 

Learn More>>

Stand Up To Cancer

Dream Team Translational Cancer Research Grant

Stand Up To Cancer (SU2C) is inviting proposals for a new $10 million Dream Team of top scientific investigators searching for new strategies to prevent or treat cancer. The new $10 million grant is open to any type of translational cancer research. 

A Letter of Intent (LOI) must be submitted by noon U.S. Eastern time on Tuesday, Sept. 5, 2017, using the proposalCENTRAL website at https://proposalcentral.altum.com.  

An SU2C Scientific Advisory Committee will review the Letters of Intent and select several teams to be invited to submit a full proposal. The deadline for invited full proposals is noon ET on Tuesday, Jan. 16, 2018, using the proposalCENTRAL website at https://proposalcentral.altum.com


Other


Innovative Molecular Analysis Technologies (IMAT) Program – related announcements:  
These announcements are in advance of the formal FOA to allow for planning your submissions.  FOA is expected in December with an expected application submission deadline in February 2016.  
• Notice of Intent to Publish a Funding Opportunity Announcement for Innovative Molecular and Cellular Analysis Technologies for Cancer Research (R21)
National Cancer Institute
• Notice of Intent to Publish a Funding Opportunity Announcement for Advanced Development and Validation of Emerging Molecular Analysis Technologies for Cancer Research (R33) 
National Cancer Institute
• Notice of Intent to Publish a Funding Opportunity Announcement for Innovative Technologies for Cancer-Relevant Biospecimen Science (R21) 
National Cancer Institute
• Notice of Intent to Publish a Funding Opportunity Announcement for Advanced Development and Validation of Technologies for Cancer-Relevant Biospecimen Science (R33)
National Cancer Institute

The Yale Cancer Center Internal Grant Program aims to provide funds for innovative, high quality start-up cancer research programs and provide new investigators with experience and guidance in the grant-writing process. 

The criteria for funding is high quality, innovative cancer research with a likelihood to result in NIH-funded cancer research and encourage collaborations within YCC. Grant competitions will be announced in DirectConnect and will undergo an anonymous NIH-style peer review with written reviews provided to applicants. 

Click to see all the Internal Grants from 2012-2016

Yale SPORE in Lung Cancer Developmental Research Program Award

Provide support of up to $50,000 for innovative pilot projects focused on a broad spectrum of research, and/or technology development applicable to human lung cancer prevention, early detection and/or other population science research. 

Those interested in applying, please contact Ed Kaftan PRIOR to starting your application. Edward.Kaftan@yale.edu; 203-737-7472

Full applications due no later than 9:00 AM on July 24, 2017

Learn More>>



Stand Up To Cancer

You are invited to submit an LOI to YCC leadership to be selected as a Yale nominee for the Stand Up To Cancer Convergence Grants. Stand Up To Cancer is requesting applications for proposals to form collaborative teams to address key questions about the human immune system’s role in cancer development and treatment. Please review the attached RFA for more details. The deadline for the internal LOI is May 24th and must be emailed to christina.dreyfus@yale.edu.


Scholar Awards Program 
 
PEW SCHOLARS PROGRAM IN THE BIOMEDICAL SCIENCES: Internal Deadline- June 1, 2017


SEARLE SCHOLARS PROGRAM: Internal Deadline- June 1, 2017


THE HARTWELL FOUNDATION 2017 INDIVIDUAL BIOMEDICAL RESEARCH AWARD: Internal Deadline- June 1, 2017


Program in Innovative Therapeutics for Connecticut's Health (PITCH) 

The Program in Innovative Therapeutics for Connecticut’s Health (PITCH) fuels target validation based on innovative research ideas born in laboratories from Yale University and the University of Connecticut. With a grant from the State of Connecticut’s Bioscience Innovation Fund, this three-year, $10 million dollar program provides translational research resources to generate prototype therapeutics that address unmet clinical needs. 

Please contact Jane Merkel for more information, janie.merkel@yale.edu

Yale Cancer Center 2017 Internal Pilot Grant Program



2016 Class of 61 YCC Research Award 

In order to recognize significant accomplishment and outstanding promise in cancer research, Yale Cancer Center is pleased to announce the opening of the competition for the 2016 Class of ’61 Yale Cancer Center Research Award. This annual Award recognizes significant accomplishment in cancer research at Yale University by a young member of the faculty, coupled with the expectation for future outstanding contributions to our understanding of the causes and cures for cancer.

YCCI Scholar Awards

We are pleased to announce a request for applications for YCCI Scholar Awards, which provide salary and/or research funds to a select number of junior faculty members who are strongly committed to careers in clinical research, community-based research or translational research.


Pew-Stewart Scholars Program for Cancer Research 

An internal competition for a new national grant program for recently appointed assistant professors to conduct cancer research. Assistant professors appointed after July 15, 2013 are eligible for consideration. 

SPORE in Skin Cancer Program Awards

Learn More>>
            

SPORE in Lung Cancer Program Awards

Learn More>>

LungSPORE@yale.edu     


Lion Heart Grants
  • Funding amount based on fundraising annually done by Lion Hearts
  • For Yale Cancer Center members only 
  • To support breast cancer research
  • Committee of Yale Cancer Center members and Lion Heart members review and select grant recipients
  • Administered by Anees Chagpar

V Foundation Pediatric Cancer Grants

  • ONE NOMINEE TO APPLY FOR EITHER THE V SCHOLAR OR TRANSLATIONAL AWARD
  • The nominee must be nominated by their Cancer Center Director if the research institution is a cancer center. If the research institution is not a cancer center, then the department chair or other senior research administrative official who is responsible for the internal nominee 
  • Applicant must be employed at a non-profit research institution 
  • Administered by Gary Kupfer  

American Cancer Society Institutional Research Grants

  • $30,000 for one year
  • For assistant professors only
  • Prior national research grant disqualifies
  • Four awards per year
  • Usually reviewed in December
  • Administered by Joann Sweasy


Rausch Foundation Grants in Community Health

  • $30,000-$50,000 for one year
  • Population science focus
  • Priority to projects with impact to New Haven
  • Administered by Melinda Irwin 


YCC Pilot Grants

  • $50,000 for one year
  • All YCC members eligible to apply
  • Specific project proposed by individual investigator
  • Seven or eight awards per year, distributed among all seven research programs
  • Usually reviewed in Spring
  • Administered by Joann Sweasy
  • RFAs will be posted in January 2017, along with other deadline information
  • For more information please contact Jan Zulkeski


T-TARE Award

  • Up to $200,000 for one year
  • For teams of investigators
  • Research with a translational focus
  • Major goal is to generate data and evidence of collaboration for multi-investigator grant application
  • Administered by Roy Herbst

Head and Neck Cancer T-TARE Award - July 1, 2016 - June 30, 2017


Yale Discovery Fund Grants

  • $450,000 to be spent over three years
  • High-risk/high-reward cancer research
  • Multidisciplinary collaborative research
  • Hope to fund 3 – 4 each year
  • Administered by Dan DiMaio


Leslie Warner Postdoctoral Fellowship

  • ~$42,000 for one year
  • Fellows working in YCC member laboratories eligible to apply
  • Must be in first year of fellowship
  • Four awards every other year
  • Usually reviewed in fall
  • Review organized by Karen Anderson